The durability of long-lasting insecticidal nets treated with and without piperonyl butoxide (PBO) in Uganda.
F. Mechan, A. Katureebe, V. Tuhaise, M. Mugote, A. Oruni, I. Onyige, K. Bumali, J. Thornton, K. Maxwell, M. Kyohere, M. R. Kamya, P. Mutungi, S. P. Kigozi, A. Yeka, J. Opigo, C. Maiteki-Sebuguzi, S. Gonahasa, J. Hemingway, G. Dorsey, L. J. Reimer, S. G. Staedke, M. J. Donnelly, A. Lynd
Abstract
Long Lasting Insecticidal Nets (LLINs) supplemented with the synergist piperonyl butoxide have been developed in response to growing pyrethroid resistance however their durability in the field remains poorly described. A pragmatic cluster-randomised trial was embedded into Ugandas 2017-2018 distribution to compare the durability of LLINs with and without PBO A total of 104 clusters were included with each receiving one of four LLIN products, two with pyrethroid+PBO (Olyset Plus and PermaNet 3.0) and two pyrethroid-only (Olyset Net and PermaNet 2.0). Nets were sampled at baseline, 12, and 25 months post-distribution to assess physical condition, chemical content, and bioefficacy. Physical condition was quantified using proportionate Hole Index and chemical content measured using high-performance liquid chromatography. Bioefficacy was assessed with three-minute WHO Cone and Wireball assays using pyrethroid-resistant An. gambiae, with 1hr knockdown and 24hr mortality recorded. There was no difference in physical durability between LLIN products assessed (p=0.644). The pyrethroid content of all products remained relatively stable across timepoints but PBO content declined by 55% (p<0.001) and 58% (p<0.001) for Olyset Plus and PermaNet 3.0 respectively. Both PBO LLINs were highly effective against pyrethroid-resistant mosquitoes when new, knocking down all mosquitoes. However, bioefficacy declined over time with Olyset Plus knocking down 45.72% (95% CI: 22.84-68.62, p=0.021) and Permanet 3.0 knocking down 78.57% (95% CI: 63.57-93.58, p<0.001) after 25 months. Here we demonstrate that both Olyset Plus and PermaNet 3.0 are as durable as their pyrethroid-only equivalents and had superior bioefficacy against pyrethroid-resistant An. gambiae. However, the superiority of PBO-LLINs decreased with operational use, correlating with a reduction in total PBO content. This decline in bioefficacy after just two years is concerning and there is an urgent need to assess the durability of PBO LLINs in other settings.
02 /Specification & Classification
Click any tag to browse matching papers- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Insecticide resistance characteristic of Anopheles vector species successfully controlled by deployment of pyrethroid and PBO long lasting insecticidal treated nets (LLINs) in Tanzania
Johnson Matowo, David Weetman, … Natacha Protopopoff·bioRxiv·Mar 19, 2021
- Assessing the additional effects of piperonyl butoxide (PBO) exposure on Anopheles mosquitoes
Rhosheen Mthawanji, Polius G. Pinda, … Christopher M. Jones·bioRxiv·Jun 19, 2026
- Can pyrethroid-piperonyl butoxide (PBO) nets reduce the efficacy of indoor residual spraying with pirimiphos-methyl against pyrethroid-resistant malaria vectors?
- Pyrethroid Resistance Intensity of Anopheles gambiae sensu lato (Diptera: Culicidae) from Phase II Hut Trial Station in KOLOKOPE, Eastern Plateau Togo: A Potential Site to Assess the Next Generation of Long- Lasting Insecticidal Nets
K. M. Ahadji-Dabla, J. Chabi, … G. K. Ketoh·bioRxiv·Aug 19, 2020
- Insecticidal roof barriers mounted on untreated bednets can be as effective against Anopheles gambiae s.l. as insecticidal bednets
A. J. Abbott, A. Matope, … P. McCall·bioRxiv·Jun 19, 2023
- Reduced long-lasting insecticidal net efficacy and pyrethroid insecticide resistance are associated with over-expression of CYP6P4, CYP6P3 and CYP6Z1 in populations of Anopheles coluzzii from South-East Cote d Ivoire
Anne Meiwald, Emma Clark, … Louisa Alexandra Messenger·The Journal of Infectious DiseasesPeer-reviewed·Nov 2, 2020